SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company. It offers SOMAmers (Slow-Offrate Modified Aptamers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and SOMAscan that provides protein detection and equipment. The company’s SOMAmer/SOMAscan technology enables to discover protein biomarker signatures; drug discovery and development; and clinical diagnostics. Its products have applications in the diagnostics of various diseases in oncology, neurology, cardiovascular and metabolic disease, and other diseases and conditions. SomaLogic, Inc. was founded in 1999 and is headquartered in Boulder, Colorado.

Company Growth (employees)
Boulder, US
Size (employees)
200 (est)
SomaLogic was founded in 2000 and is headquartered in Boulder, US

Key People/Management at SomaLogic

Larry Gold

Larry Gold

Chairman and CEO
Scott Kothlow

Scott Kothlow

Stephen A. Williams

Stephen A. Williams

Chief Medical Officer
Nebojsa Janjic

Nebojsa Janjic

Chief Science Officer

SomaLogic Office Locations

SomaLogic has an office in Boulder
Boulder, US (HQ)
2945 Wilderness Pl
Show all (1)

SomaLogic Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$541.5 m

Latest funding size

$200 m

Time since last funding

20 days


SomaLogic's latest funding round in January 2018 was reported to be $200 m. In total, SomaLogic has raised $541.5 m

SomaLogic's Web-traffic and Trends

SomaLogic Online and Social Media Presence

SomaLogic News and Updates

Aptamers Market to Surge Past US$ 10,407 Million by 2025 due to Widened Application Area

Global Aptamers Market, By Type (Nucleic Acid Aptamers, Peptide Aptamers), Application (Diagnostics, Therapeutics, Research and Development), End User (Biotechnology and Pharmaceutical Companies, Contract Research Organization, Academic and Research Institutions), and Geography - Insights, Size, Sha…

SomaLogic Company Life and Culture

You may also be interested in